UP

FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE's vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.

Axar.az reports that the trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.

Pfizer asked for the FDA's approval for the use of its treatment in kids earlier this month.

Date
2021.10.22 / 20:31
Author
Axar.az
See also

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla